BlueCrest Capital Management’s UnitedHealth UNH Stock Holding History

BlueCrest Capital Management’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-137,591	Closed	-$42.9M	–	219
2025 Q2	$42.9M	Buy	+137,591	New	+$52.6M	1.64%	13
2024 Q2	–	Sell	-3,387	Closed	-$1.68M	–	223
2024 Q1	$1.68M	Sell	3,387 -7,141	-68%	-$3.63M	0.08%	132
2023 Q4	$5.54M	Buy	10,528 +5,190	+97%	+$2.77M	0.21%	92
2023 Q3	$2.69M	Buy	5,338 +2,623	+97%	+$1.29M	0.12%	113
2023 Q2	$1.3M	Buy	+2,715	New	+$1.33M	0.04%	130
2019 Q3	–	Sell	-9,561	Closed	-$2.33M	–	672
2019 Q2	$2.33M	Buy	+9,561	New	+$2.3M	0.17%	92
2018 Q4	–	Sell	-5,409	Closed	-$1.44M	–	1424
2018 Q3	$1.44M	Buy	5,409 +1,693	+46%	+$440K	0.04%	341
2018 Q2	$912K	Buy	+3,716	New	+$892K	0.02%	565
2017 Q2	–	Sell	-44,068	Closed	-$7.23M	–	1113
2017 Q1	$7.23M	Buy	+44,068	New	+$7.22M	0.34%	88
2015 Q3	–	Sell	-15,775	Closed	-$1.93M	–	1050
2015 Q2	$1.93M	Buy	+15,775	New	+$1.87M	0.06%	359
2015 Q1	–	Sell	-7,904	Closed	-$799K	–	758
2014 Q4	$799K	Buy	+7,904	New	+$749K	0.03%	395

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlueCrest Capital Management's UNH Position: Q3 2025 in Review

BlueCrest Capital Management sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 137,591 shares — an estimated $42.9M sold.

BlueCrest Capital Management first reported a position in UNH in Q4 2014 and held it in 11 quarters. The position peaked at $42.9M in Q2 2025. 3,159 funds tracked by Wall St. Rank hold UNH as of Q3 2025.

BlueCrest Capital Management reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
BlueCrest Capital Management sold 137,591 UnitedHealth shares in Q3 2025, an estimated $42.9M.
BlueCrest Capital Management first reported a position in UnitedHealth in Q4 2014 and held it in 11 quarters.
BlueCrest Capital Management's UnitedHealth position peaked at $42.9M in Q2 2025.
3,159 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.

Based on BlueCrest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.